What are the dosing guidelines, contraindications, and safety considerations for using lidocaine as a local anesthetic?

Lidocaine for Local Anesthesia

For adults, administer no more than 4.5 mg/kg of lidocaine without epinephrine or 7.0 mg/kg of lidocaine with epinephrine in a single treatment session. 1

Maximum Safe Dosing

Adults

• Lidocaine without epinephrine: 4.5 mg/kg (maximum 300 mg)
• Lidocaine with epinephrine: 7.0 mg/kg (maximum 500 mg)
• For multistage procedures (e.g., Mohs surgery): up to 500 mg of 1% lidocaine delivered incrementally over several hours 1

Pediatric Patients

• Lidocaine without epinephrine: 1.5-2.0 mg/kg
• Lidocaine with epinephrine: 3.0-4.5 mg/kg 1

These dosing limits are based on expert consensus and manufacturer recommendations, though the true maximum safe dose remains unknown 1. Recent research confirms that even doses up to 21.6 mg/kg with epinephrine in dilute solutions yield plasma levels well below toxic thresholds 2.

Critical Safety Measures to Prevent Systemic Toxicity

Always implement these four steps to minimize risk of local anesthetic systemic toxicity (LAST): 1

1. Use the lowest effective dose for the procedure
2. Aspirate before each injection to avoid intravascular administration
3. Inject incrementally rather than as a single bolus
4. Continuously monitor and communicate with the patient for early toxicity signs

Recognizing Early Toxicity

Watch for this progression of symptoms 1, 3:

• Initial CNS excitation: Circumoral numbness, facial tingling, metallic taste, slurred speech, auditory changes
• Cardiovascular: Hypertension and tachycardia initially
• Advanced CNS: Seizures or depression
• Severe: Cardiac failure or arrest

Contraindications and Special Populations

True Lidocaine Allergy (rare, <1% of reactions)

When genuine immunologic allergy exists, use alternatives: 1

• Ester-type local anesthetics (cross-reaction is rare)
• 1% diphenhydramine (slower onset: 5 min vs. 1 min for lidocaine)
• Bacteriostatic normal saline (0.9% benzyl alcohol in saline with epinephrine)

High-Risk Scenarios Requiring Dose Reduction 4, 5

• End-stage pregnancy
• Advanced age (especially for epidural/spinal blocks)
• Renal failure (uremia increases initial uptake)
• Hepatic disease (reduced clearance for repeated dosing)
• Cardiac disease (reduced clearance)
• Barrier-compromised skin (burns, ulcers, inflammatory dermatoses dramatically accelerate absorption) 5

Optimizing Efficacy and Reducing Injection Pain

Add Epinephrine

Always add epinephrine (1:100,000 to 1:200,000) unless contraindicated - this allows higher safe doses and prolongs anesthetic duration 1. The historical dogma against epinephrine use in digits, nose, ears, and penis has been thoroughly debunked by over 200,000 documented cases showing excellent safety 5.

Buffer the Solution

Mix 8.4% sodium bicarbonate with 1% lidocaine in a 1:9 or 1:10 ratio to significantly reduce injection pain 1. Do not buffer bupivacaine as precipitation reduces efficacy.

Additional Pain-Reduction Techniques 1

• Slow infiltration rate
• Warm solution to 40°C
• Vibrate the skin during injection
• Cold air skin cooling

Tumescent Anesthesia (Specialized High-Volume Technique)

For office-based liposuction specifically: 1, 6

• Maximum dose: 55 mg/kg of lidocaine with epinephrine (validated for patients 43.6-81.8 kg)
• Use dilute concentrations (≤1 g/L lidocaine)
• This dramatically higher dose is safe due to slow systemic absorption from subcutaneous tissue
• Research shows doses up to 45 mg/kg with liposuction yield serum levels <6 μg/mL (below mild toxicity threshold) 6

Common Pitfalls to Avoid

1. Calculation errors: Use the simple formula to prevent overdosing 1
2. Combining amide anesthetics without dose adjustment: When using multiple amide agents (lidocaine, bupivacaine, prilocaine), apply the fractional dose rule - additive toxicity occurs 3
3. Ignoring patient weight: Always calculate mg/kg, especially in pediatric and low-weight patients 7
4. Topical application on compromised skin: Dramatically accelerated absorption can cause toxicity even with standard topical doses 5
5. Inadequate monitoring: LAST can occur even with appropriate dosing - maintain vigilance 7

Emergency Preparedness

Have intravenous lipid emulsion (ILE) immediately available - this is the specific rescue therapy for severe cardiovascular LAST and has transformed outcomes from often-fatal to manageable 3, 5. Airway support and oxygenation remain primary interventions for CNS toxicity 3.